Entering text into the input field will update the search result below

ViiV Healthcare seeks expanded label for HIV treatment Cabenuva

Feb. 24, 2021 1:12 PM ETGSK plc (GSK) Stock, PFE StockBy: SA News Team
  • ViiV Healthcare, specialist HIV company majority owned by GlaxoSmithKline (NYSE:GSK), with Pfizer <<NYSE:PFE>> and Shionogi as shareholders, announces the submission of a supplemental New Drug Application ((sNDA)) to the US FDA for the expanded use of Cabenuva (cabotegravir, rilpivirine).
  • The application

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
GSK
--
PFE
--